AngioDynamics (ANGO) vs Baxter International (BAX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Baxter International (BAX) has outperformed AngioDynamics (ANGO) over the past year, gaining 5.1% versus a gain of 1.0%. Over five years, ANGO leads with a -59.0% price change compared with -70.0% for BAX. Baxter International is the larger company by market cap ($12.36 billion vs $472.3 million), about 26.2 times the size.
Baxter International pays a dividend yielding 0.84%, while AngioDynamics does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANGO | BAX |
|---|---|---|
| Share price | $11.23 | $23.90 |
| Market cap | $472.27M | $12.36B |
| 1-day change | -20.86% | -0.29% |
| YTD return | -12.54% | +25.07% |
| 1-year return | +0.99% | +5.05% |
| 5-year return | -58.97% | -70.01% |
| Forward P/E | — | 11.72 |
| EPS (TTM) | $-0.88 | $-1.88 |
| Dividend yield | 0.00% | 0.84% |
| Annual dividend | $0.00 | $0.20 |
| Revenue (latest FY) | — | $11.24B |
| Revenue growth (YoY) | — | +5.72% |
| Net income (latest FY) | — | $-957.00M |
| Gross margin | — | 30.05% |
| Operating margin | — | -2.74% |
| Net margin | — | -8.51% |
| 52-week high | $16.29 | $30.00 |
| 52-week low | $9.39 | $15.73 |
| Distance from 52-week high | -31.06% | -20.33% |
| Analyst consensus | none | hold |
| Avg. price target upside | +78.09% | +16.82% |
| Average volume | 557.83K | 6.66M |
| Shares outstanding | 42.05M | 517.00M |
| Employees | 632 | 37,500 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Baxter International is about 26.2 times larger than AngioDynamics by market value ($12.36B vs $472.27M).
About AngioDynamics
ANGO stock →AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments.
Healthcare · Medical Instruments & Supplies · 632 employees
About Baxter International
BAX stock →Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals.
Healthcare · Medical Instruments & Supplies · 37,500 employees
ANGO vs BAX FAQ
Which is bigger, AngioDynamics or Baxter International?
Baxter International (BAX) is larger, with a market capitalization of $12.36B compared with $472.27M for AngioDynamics (ANGO).
Which stock has performed better over the past year, ANGO or BAX?
BAX returned +5.05% over the past 12 months, compared with +0.99% for ANGO (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, AngioDynamics or Baxter International?
Baxter International pays a dividend yielding 0.84%, while AngioDynamics does not currently pay a regular dividend.
Are AngioDynamics and Baxter International in the same industry?
Yes. Both are classified in the Medical Instruments & Supplies industry within the Healthcare sector.